Mice tolerate siRNAs

Small interfering RNAs (siRNAs) appear to silence genes in mice without triggering an immune response, according to researchers at the California Institute of Technology in Pasadena.

| 1 min read

Register for free to listen to this article
Listen with Speechify
0:00
1:00
Share

Getty Images

Small interfering RNAs (siRNAs) appear to silence genes in mice without triggering an immune response, according to researchers at the California Institute of Technology in Pasadena. Mark Davis and colleagues gave mice naked synthetic siRNAs against fatty acid synthase (FAS), c-MYC, or luciferase, through intraperitoneal injections or via the tail vein using either low-pressure (1% volume/weight) or high-pressure (10% volume/weight) methods.

Enzyme-linked immunosorbent assay (ELISA) showed that siRNA failed to trigger a strong type I interferon alpha response regardless of the siRNA or type of injection method. In comparison, polyinosinic acid:polycytidylic acid – poly(I:C), a long, double-stranded RNA analog – triggered strong interferon responses. The researchers also looked for effects mediated by Toll-like receptors 3 and 9, which are thought to recognize siRNA and trigger interferon upregulation. ELISA analysis showed that while poly(I:C) triggered a strong interleukin-12 response, the siRNAs did not.

High-pressure tail-vein injection of siRNA against ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

  • Charles Choi

    This person does not yet have a bio.

Published In

Share
3D illustration of a gold lipid nanoparticle with pink nucleic acid inside of it. Purple and teal spikes stick out from the lipid bilayer representing polyethylene glycol.
February 2025, Issue 1

A Nanoparticle Delivery System for Gene Therapy

A reimagined lipid vehicle for nucleic acids could overcome the limitations of current vectors.

View this Issue
Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

Enhancing Therapeutic Antibody Discovery with Cross-Platform Workflows

sartorius logo
Considerations for Cell-Based Assays in Immuno-Oncology Research

Considerations for Cell-Based Assays in Immuno-Oncology Research

Lonza
An illustration of animal and tree silhouettes.

From Water Bears to Grizzly Bears: Unusual Animal Models

Taconic Biosciences
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo

Products

Photo of a researcher overseeing large scale production processes in a laboratory.

Scaling Lentiviral Vector Manufacturing for Optimal Productivity

Thermo Fisher Logo
An illustration of an mRNA molecule in front of a multicolored background.

Generating High-Quality mRNA for In Vivo Delivery with lipid nanoparticles

Thermo Fisher Logo
Tecan Logo

Tecan introduces Veya: bringing digital, scalable automation to labs worldwide

Explore a Concise Guide to Optimizing Viral Transduction

A Visual Guide to Lentiviral Gene Delivery

Takara Bio